JCMAX
Price
$62.55
Change
-$0.58 (-0.92%)
Updated
Dec 27 closing price
VIMSX
Price
$72.82
Change
-$0.65 (-0.88%)
Updated
Dec 27 closing price
Ad is loading...

JCMAX vs VIMSX

Header iconJCMAX vs VIMSX Comparison
Open Charts JCMAX vs VIMSXBanner chart's image
JPMorgan Mid Cap Equity A
Price$62.55
Change-$0.58 (-0.92%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Investor
Price$72.82
Change-$0.65 (-0.88%)
VolumeN/A
CapitalizationN/A
JCMAX vs VIMSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JCMAX vs. VIMSX commentary
Dec 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JCMAX is a StrongBuy and VIMSX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 190B vs. JCMAX (5.31B). VIMSX pays higher dividends than JCMAX: VIMSX (1.38) vs JCMAX (0.28). JCMAX was incepted earlier than VIMSX: JCMAX (15 years) vs VIMSX (27 years). JCMAX is a more actively managed with annual turnover of: 40.00 vs. VIMSX (13.00). JCMAX has a lower initial minimum investment than VIMSX: JCMAX (1000) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 14.36 vs. JCMAX (10.94). VIMSX return over 5 years is better than : 51.28 vs. JCMAX (28.06).
JCMAXVIMSXJCMAX / VIMSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years27 years-
Gain YTD11.48714.93677%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets5.31B190B3%
Annual Yield % from dividends0.281.3820%
Returns for 1 year10.9414.3676%
Returns for 3 years5.605.47102%
Returns for 5 years28.0651.2855%
Returns for 10 years43.08118.1136%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WST333.22-0.21
-0.06%
West Pharmaceutical Services
INVA17.55-0.10
-0.57%
Innoviva
FULC4.79-0.05
-1.03%
Fulcrum Therapeutics
IQ2.08-0.04
-1.89%
iQIYI
DUOT6.38-0.31
-4.63%
Duos Technologies Group